{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#36 - Stella K. Vnook, CEO at Likarda","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/49666193\"></iframe>","width":"100%","height":180,"duration":1144,"description":"Join us on the latest episode! Our Guest: Stella K. Vnook, CEO at Likarda.\nWhat you'll get out of this episode:\nStella Vnook, CEO of Likarda, discusses her transition from a science background to the business side of biotech and her journey to becoming CEO.\nLikarda specializes in core-shell spherification, creating beads with cells for targeted drug delivery, improving viability and efficacy.\nThe company aims to enhance cell therapies, especially in liver cells and hormone therapy, and simplify cell transport logistics.\nLikarda's future goals include launching off-the-shelf products for osteoarthritis and advancing partnerships in cell therapy and regenerative medicine.\nFunding strategies and future plans involve a Series A funding round, non-dilutive funding, and efficient use of resources to scale up and innovate.\n\nTo learn more about our guests and their companies:\nLinkedIn: https://www.linkedin.com/in/vnook/\nCompany LinkedIn: https://www.linkedin.com/company/likarda-llc/\nWebsite: https://likarda.com/\n\nOur sponsor for this episode are:\nSage Growth Partners https://sage-growth.com/\nBioBreakthroughs is part of the Slice of Healthcare podcast network:\nLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}